Juanita Dortch-Carnes

Juanita Dortch-Carnes

Auto-generated profile, based on publicly available information

Juanita Dortch-Carnes

Department of Pharmacology and Toxicology Morehouse School of Medicine, 720 Westview Drive, SW, Atlanta, GA 30310-1495, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2006 in Pharmacology
Verified
Journal Article
Closed access
JDJuanita Dortch-Carnes
Juanita Dortch-Carnes
KRKaren R.M. Russell
Karen R.M. Russell
The present study was performed to evaluate the role of nitric oxide in the intraocular pressure (IOP) lowering effect and in the miotic action of morphine. The IOP was measured in conscious, normal, dark-adapted New Zealand white rabbits using a calibrated pneumatonometer. Experiments were conducted, in which rabbits’ eyes were treated with morphine topically and unilaterally, while the fellow eyes received vehicle. IOP and pupil diameter (PD) measurements were taken 0.5 and 0 h before morphine administration and 0.5, 1, 2, 3, 4, and 5 h thereafter. The effects of a nonselective opioid receptor antagonist (naloxone), a nitric oxide synthase inhibitor (Nω-nitro-L-arginine methyl ester; L-NAME), and a sulfhydryl reagent (reduced L-glutathione; GSH) on morphine-mediated changes in IOP and PD were also determined. Morphine (10, 33, and 100 µg) produced concen- tration-dependent decreases in IOP and reduced PD in both treated and untreated eyes of New Zealand white rabbits. IOP-lowering effect of morphine (100 µg) and reduction in PD were both significantly inhibited by pretreatment with naloxone (100 µg), L-NAME (0.5%), or GSH (100 µg). The results from this study indicate that morphine-induced ocular hypotension and reduction in PD are opioid-receptor-mediated responses that are associated with the release of nitric oxide. Because the µ3 opioid receptor subtype has a nitric-oxide-releasing activity and is sensitive to inactivation by GSH, it is concluded that morphine-induced ocular hypotension and miosis are mediated, in part, by activation of µ3 opioid receptors.


1 November 2009 in Experimental Eye Research
Verified
Journal Article
Closed access
JDJuanita Dortch-Carnes
Juanita Dortch-Carnes
KRKaren Russell Randall
Karen Russell Randall